Phibro Animal Health Corp (PAHC)
23.72
-0.04
(-0.15%)
USD |
NASDAQ |
Nov 22, 16:00
23.72
0.00 (0.00%)
After-Hours: 20:00
Phibro Animal Health Revenue (Annual): 1.018B for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.018B |
| June 30, 2023 | 977.89M |
| June 30, 2022 | 942.26M |
| June 30, 2021 | 833.35M |
| June 30, 2020 | 800.35M |
| June 30, 2019 | 828.00M |
| June 30, 2018 | 819.98M |
| Date | Value |
|---|---|
| June 30, 2017 | 764.28M |
| June 30, 2016 | 751.53M |
| June 30, 2015 | 748.59M |
| June 30, 2014 | 691.91M |
| June 30, 2013 | 653.15M |
| June 30, 2012 | 654.10M |
| June 30, 2011 | 618.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
800.35M
Minimum
2020
1.018B
Maximum
2024
914.31M
Average
942.26M
Median
2022
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| Haemonetics Corp | 1.309B |
| Baxter International Inc | 14.81B |
| Globus Medical Inc | 1.568B |
| Insulet Corp | 1.697B |